266 related articles for article (PubMed ID: 9153607)
1. The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache.
Cull RE; Price WH; Dunbar A
J Neurol Neurosurg Psychiatry; 1997 May; 62(5):490-5. PubMed ID: 9153607
[TBL] [Abstract][Full Text] [Related]
2. Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group.
Göbel H; Winter P; Boswell D; Crisp A; Becker W; Hauge T; Mihout B; Niewold J; Tørring J
Clin Ther; 2000 Aug; 22(8):981-9. PubMed ID: 10972634
[TBL] [Abstract][Full Text] [Related]
3. Oral sumatriptan in the acute treatment of migraine and migraine recurrence in general practice.
Scott RJ; Aitchison WR; Barker PR; McLaren GI
QJM; 1996 Aug; 89(8):613-22. PubMed ID: 8935482
[TBL] [Abstract][Full Text] [Related]
4. Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine.
Diamond S; Elkind A; Jackson RT; Ryan R; DeBussey S; Asgharnejad M
Arch Fam Med; 1998; 7(3):234-40. PubMed ID: 9596457
[TBL] [Abstract][Full Text] [Related]
5. Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial.
Cady RC; Ryan R; Jhingran P; O'Quinn S; Pait DG
Arch Intern Med; 1998 May; 158(9):1013-8. PubMed ID: 9588435
[TBL] [Abstract][Full Text] [Related]
6. Sumatriptan. An updated review of its use in migraine.
Perry CM; Markham A
Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
[TBL] [Abstract][Full Text] [Related]
7. Oral sumatriptan in the treatment of recurrent headache.
Cady RK; Rubino J; Crummett D; Littlejohn TW
Arch Fam Med; 1994 Sep; 3(9):766-72. PubMed ID: 7987510
[TBL] [Abstract][Full Text] [Related]
8. Sumatriptan in acute migraine using a novel cartridge system self-injector. United Kingdom Study Group.
Gross ML; Kay J; Turner AM; Hallett K; Cleal AL; Hassani H
Headache; 1994; 34(10):559-63. PubMed ID: 7843948
[TBL] [Abstract][Full Text] [Related]
9. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.
Savani N; Brautaset NJ; Reunanen M; Szirmai I; Ashford EA; Hassani H; Saiers J
Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. The Sumatriptan Menstrual Migraine Study Group.
Facchinetti F; Bonellie G; Kangasniemi P; Pascual J; Shuaib A
Obstet Gynecol; 1995 Dec; 86(6):911-6. PubMed ID: 7501338
[TBL] [Abstract][Full Text] [Related]
11. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
Winner P; Ricalde O; Le Force B; Saper J; Margul B
Arch Neurol; 1996 Feb; 53(2):180-4. PubMed ID: 8639069
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial.
Thomson AN; Arthur GP; Bergin PS; Pollock M; Parkin PJ; Flanagan M; Samson SA
N Z Med J; 1993 May; 106(955):171-3. PubMed ID: 8389026
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study.
Carpay J; Schoenen J; Ahmad F; Kinrade F; Boswell D
Clin Ther; 2004 Feb; 26(2):214-23. PubMed ID: 15038944
[TBL] [Abstract][Full Text] [Related]
14. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan.
Solbach MP; Waymer RS
Obstet Gynecol; 1993 Nov; 82(5):769-72. PubMed ID: 8414324
[TBL] [Abstract][Full Text] [Related]
15. Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine.
Peikert A; Becker WJ; Ashford EA; Dahlof C; Hassani H; Salonen RJ
Eur J Neurol; 1999 Jan; 6(1):43-9. PubMed ID: 10209349
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group.
Diener HC
Cephalalgia; 1999 Jul; 19(6):581-8; discussion 542. PubMed ID: 10448545
[TBL] [Abstract][Full Text] [Related]
17. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
[TBL] [Abstract][Full Text] [Related]
19. Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice.
Jensen K; Tfelt-Hansen P; Hansen EW; Krøis EH; Pedersen OS
Cephalalgia; 1995 Oct; 15(5):423-9. PubMed ID: 8536304
[TBL] [Abstract][Full Text] [Related]
20. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group.
Eur Neurol; 1991; 31(5):323-31. PubMed ID: 1653140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
